Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1-3 Inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1-3 Inhibitors.
Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1-3 Inhibitors. ACS Chem Biol. 2021 07 16; 16(7):1266-1275.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carbamates
Cell Line, Tumor
Cell Proliferation
Drug Screening Assays, Antitumor
Histone Deacetylase Inhibitors
Humans
Lysine
Male
Mice
Sirtuin 1
Sirtuin 2
Sirtuin 3
Xenograft Model Antitumor Assays
authors with profiles
Hening Lin